G J Freeman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G J Freeman

Showing results (111-120 of 113) with videos related to

Pageof 12

Sort By:

You have reached the last page of results.This site can display upto 113 results.

The Journal of Experimental Medicine|October 4, 2000

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationG J Freeman, A J Long, Y Iwai, et al.

Nature Immunology|February 27, 2001

PD-L2 is a second ligand for PD-1 and inhibits T cell activationY Latchman, C R Wood, T Chernova, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020

Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomasS Derks, L K de Klerk, X Xu, et al.

Pageof 12

Search research articles

Showing results (111-120 of 113) with videos related to

Sort By:

Pageof 12

You have reached the last page of results.This site can display upto 113 results.

The Journal of Experimental Medicine|October 4, 2000

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationG J Freeman, A J Long, Y Iwai, et al.

Nature Immunology|February 27, 2001

PD-L2 is a second ligand for PD-1 and inhibits T cell activationY Latchman, C R Wood, T Chernova, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020

Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomasS Derks, L K de Klerk, X Xu, et al.

Pageof 12